IA
CLLS

IFP Advisors’s Cellectis CLLS Stock Holding History

IFP Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$4.95K – 3032
2020
Q4 		$5K Buy
+200
New +$4.49K ﹤0.01% 2308
2019
Q1 		– Sell
-200
Closed -$3K – 2520
2018
Q4 		$3K Hold
200
– – ﹤0.01% 3017
2018
Q3 		$6K Hold
200
– – ﹤0.01% 3111
2018
Q2 		$6K Sell
200
-150
-43% -$4.47K ﹤0.01% 3147
2018
Q1 		$10K Hold
350
– – ﹤0.01% 2777
2017
Q4 		$10K Buy
+350
New +$9.53K ﹤0.01% 2818

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIA
Capital Impact Advisors Boston, Massachusetts $247M AUM 31.15% 1-Year Est. Return

IFP Advisors's CLLS Position: Q1 2021 in Review

IFP Advisors sold out of Cellectis (CLLS) in Q1 2021, closing a stake of 200 shares — an estimated $4.95K sold.

IFP Advisors first reported a position in CLLS in Q4 2017 and held it in 6 quarters. The position peaked at $10K in Q1 2018. 81 funds tracked by Wall St. Rank hold CLLS as of Q1 2021.

  • IFP Advisors reported no remaining Cellectis position as of Q1 2021 after selling out during the quarter.
  • IFP Advisors sold 200 Cellectis shares in Q1 2021, an estimated $4.95K.
  • IFP Advisors first reported a position in Cellectis in Q4 2017 and held it in 6 quarters.
  • IFP Advisors's Cellectis position peaked at $10K in Q1 2018.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q1 2021.

Based on IFP Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.